Last reviewed · How we verify

Fibrin Pad — Competitive Intelligence Brief

Fibrin Pad (Fibrin Pad) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Hemostatic agent. Area: Surgery/Hemostasis.

phase 3 Hemostatic agent Surgery/Hemostasis Small molecule Live · refreshed every 30 min

Target snapshot

Fibrin Pad (Fibrin Pad) — Ethicon, Inc.. Fibrin Pad is a hemostatic agent that forms a fibrin clot matrix to promote rapid hemostasis and wound sealing at surgical sites.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Fibrin Pad TARGET Fibrin Pad Ethicon, Inc. phase 3 Hemostatic agent
FFP and Cryoprecipitate FFP and Cryoprecipitate The University of Texas Health Science Center, Houston marketed Blood product / Hemostatic agent
Bioseal Fibrin Sealant Bioseal Fibrin Sealant Ethicon, Inc. marketed Fibrin sealant / Hemostatic agent
Hemoblast Bellows application Hemoblast Bellows application WakeMed Health and Hospitals marketed Hemostatic agent
Blood Stopper (Ankaferd) Blood Stopper (Ankaferd) Ankara Ataturk Sanatorium Training and Research Hospital marketed Topical hemostatic agent
Haemostatic solution "Haemoblock" application Haemostatic solution "Haemoblock" application Ryazan State Medical University marketed Topical hemostatic agent
Patients receive microporous polysaccharide hemospheres. Patients receive microporous polysaccharide hemospheres. Fundación para la Investigación del Hospital Clínico de Valencia marketed Topical hemostatic agent

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Hemostatic agent class)

  1. Chang Gung Memorial Hospital · 1 drug in this class
  2. DeNova Research · 1 drug in this class
  3. Ethicon, Inc. · 1 drug in this class
  4. Mallinckrodt · 1 drug in this class
  5. Sun Yat-sen University · 1 drug in this class
  6. Swiss Cancer Institute · 1 drug in this class
  7. Takeda · 1 drug in this class
  8. WakeMed Health and Hospitals · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Fibrin Pad — Competitive Intelligence Brief. https://druglandscape.com/ci/fibrin-pad. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: